Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $2,125 | 4 | 47.0% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $1,575 | 2 | 34.8% |
| Food and Beverage | $826.06 | 10 | 18.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Heron Therapeutics, Inc. | $4,039 | 9 | $0 (2024) |
| Mallinckrodt LLC | $299.52 | 4 | $0 (2018) |
| B. Braun Medical Inc. | $108.90 | 2 | $0 (2017) |
| Edwards Lifesciences Corporation | $78.15 | 1 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $825.00 | 1 | Heron Therapeutics, Inc. ($825.00) |
| 2023 | $871.92 | 2 | Heron Therapeutics, Inc. ($871.92) |
| 2022 | $342.57 | 3 | Heron Therapeutics, Inc. ($342.57) |
| 2021 | $1,000 | 1 | Heron Therapeutics, Inc. ($1,000) |
| 2020 | $1,000 | 2 | Heron Therapeutics, Inc. ($1,000) |
| 2019 | $78.15 | 1 | Edwards Lifesciences Corporation ($78.15) |
| 2018 | $152.34 | 2 | Mallinckrodt LLC ($152.34) |
| 2017 | $256.08 | 4 | Mallinckrodt LLC ($147.18) |
All Payment Transactions
16 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 05/21/2024 | Heron Therapeutics, Inc. | ZYNRELEF (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $825.00 | General |
| Category: POST SURGICAL PAIN RELIEF | ||||||
| 05/24/2023 | Heron Therapeutics, Inc. | APONVIE (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $750.00 | General |
| Category: NAUSEAVOMITING | ||||||
| 02/01/2023 | Heron Therapeutics, Inc. | ZYNRELEF (Drug) | Food and Beverage | Cash or cash equivalent | $121.92 | General |
| Category: POST SURGICAL PAIN RELIEF | ||||||
| 12/10/2022 | Heron Therapeutics, Inc. | Zynrelef (Drug) | Food and Beverage | In-kind items and services | $117.93 | General |
| Category: Postoperative Pain | ||||||
| 12/10/2022 | Heron Therapeutics, Inc. | Zynrelef (Drug) | Food and Beverage | In-kind items and services | $99.64 | General |
| Category: Postoperative Pain | ||||||
| 03/23/2022 | Heron Therapeutics, Inc. | Zynrelef (Drug) | Consulting Fee | Cash or cash equivalent | $125.00 | General |
| Category: Postoperative Pain | ||||||
| 05/26/2021 | Heron Therapeutics, Inc. | Zynrelef (Drug) | Consulting Fee | Cash or cash equivalent | $1,000.00 | General |
| Category: Postoperative Pain | ||||||
| 06/23/2020 | Heron Therapeutics, Inc. | HTX-011 (Drug) | Consulting Fee | Cash or cash equivalent | $500.00 | General |
| 03/24/2020 | Heron Therapeutics, Inc. | HTX-011 (Drug) | Consulting Fee | Cash or cash equivalent | $500.00 | General |
| 09/27/2019 | Edwards Lifesciences Corporation | — | Food and Beverage | In-kind items and services | $78.15 | General |
| 05/16/2018 | Mallinckrodt LLC | OFIRMEV (Drug) | Food and Beverage | In-kind items and services | $67.41 | General |
| Category: ACUTE CARE | ||||||
| 04/19/2018 | Mallinckrodt LLC | OFIRMEV (Drug) | Food and Beverage | In-kind items and services | $84.93 | General |
| Category: ACUTE CARE | ||||||
| 10/23/2017 | Mallinckrodt LLC | OFIRMEV (Drug) | Food and Beverage | In-kind items and services | $75.10 | General |
| Category: ACUTE CARE | ||||||
| 06/02/2017 | B. Braun Medical Inc. | CONTIPLEX Anesthesia Catheters (Device) | Food and Beverage | Cash or cash equivalent | $33.32 | General |
| Category: Pain Control | ||||||
| 05/03/2017 | B. Braun Medical Inc. | Pencan Spinal Needles (Device) | Food and Beverage | Cash or cash equivalent | $75.58 | General |
| Category: Pain Control | ||||||
| 01/11/2017 | Mallinckrodt LLC | OFIRMEV (Drug) | Food and Beverage | In-kind items and services | $72.08 | General |
| Category: ACUTE CARE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 271 | 298 | $84,659 | $18,279 |
| 2022 | 7 | 275 | 305 | $77,417 | $17,988 |
| 2021 | 8 | 368 | 442 | $116,935 | $27,964 |
| 2020 | 8 | 446 | 489 | $134,047 | $32,404 |
All Medicare Procedures & Services
37 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 82 | 107 | $19,260 | $6,471 | 33.6% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 66 | 66 | $22,440 | $6,454 | 28.8% |
| 64447 | Injection of anesthetic agent and/or steroid into thigh nerve (femoral nerve) | Facility | 2023 | 41 | 41 | $23,247 | $1,982 | 8.5% |
| 64488 | Injection of local anesthetic for abdominal wall pain control on both sides using imaging guidance | Facility | 2023 | 20 | 20 | $6,540 | $988.09 | 15.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 12 | 12 | $2,256 | $906.36 | 40.2% |
| 76942 | Ultrasonic guidance for needle placement | Facility | 2023 | 34 | 34 | $9,116 | $783.09 | 8.6% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 16 | 18 | $1,800 | $694.26 | 38.6% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 91 | 121 | $21,780 | $6,771 | 31.1% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 38 | 38 | $12,920 | $4,030 | 31.2% |
| 64447 | Injection of anesthetic agent and/or steroid into thigh nerve | Facility | 2022 | 32 | 32 | $18,144 | $1,338 | 7.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2022 | 12 | 12 | $3,576 | $1,281 | 35.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 12 | 12 | $3,576 | $1,190 | 33.3% |
| 76942 | Ultrasonic guidance for needle placement | Facility | 2022 | 48 | 48 | $8,142 | $1,175 | 14.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 14 | 14 | $2,632 | $1,084 | 41.2% |
| 64488 | Injection of local anesthetic for abdominal wall pain control on both sides using imaging guidance | Facility | 2022 | 15 | 15 | $4,905 | $822.32 | 16.8% |
| 76942 | Ultrasonic guidance for needle placement | Office | 2022 | 13 | 13 | $1,742 | $297.68 | 17.1% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 126 | 186 | $33,480 | $10,567 | 31.6% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 67 | 68 | $23,120 | $7,097 | 30.7% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 28 | 28 | $8,344 | $3,039 | 36.4% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 17 | 20 | $4,194 | $1,716 | 40.9% |
| 64999 | Nervous system procedure | Facility | 2021 | 13 | 21 | $9,396 | $1,341 | 14.3% |
| 64447 | Injection of anesthetic agent and/or steroid into femoral nerve of thigh | Facility | 2021 | 25 | 25 | $14,742 | $1,086 | 7.4% |
| 76942 | Ultrasonic guidance imaging supervision and interpretation for insertion of needle | Facility | 2021 | 38 | 38 | $5,092 | $947.72 | 18.6% |
| 64447 | Injection of anesthetic agent and/or steroid into femoral nerve of thigh | Office | 2021 | 17 | 18 | $10,773 | $787.55 | 7.3% |
| 64488 | Injections of local anesthetic for pain control and abdominal wall analgesia on both sides | Facility | 2021 | 14 | 14 | $4,578 | $785.26 | 17.2% |
About Jacques Chelly
Jacques Chelly is a Specialist healthcare provider based in Pittsburgh, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/06/2006. The National Provider Identifier (NPI) number assigned to this provider is 1376515148.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Jacques Chelly has received a total of $4,526 in payments from pharmaceutical and medical device companies, with $825.00 received in 2024. These payments were reported across 16 transactions from 4 companies. The most common payment nature is "Consulting Fee" ($2,125).
As a Medicare-enrolled provider, Chelly has provided services to 1,360 Medicare beneficiaries, totaling 1,534 services with total Medicare billing of $96,634. Data is available for 4 years (2020–2023), covering 37 distinct procedure/service records.
Practice Information
- Specialty Specialist
- Location Pittsburgh, PA
- Active Since 02/06/2006
- Last Updated 05/24/2021
- Taxonomy Code 174400000X
- Entity Type Individual
- NPI Number 1376515148
Products in Payments
- Zynrelef (Drug) $1,343
- HTX-011 (Drug) $1,000
- ZYNRELEF (Drug) $946.92
- APONVIE (Drug) $750.00
- OFIRMEV (Drug) $299.52
- Pencan Spinal Needles (Device) $75.58
- CONTIPLEX Anesthesia Catheters (Device) $33.32
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Specialist Doctors in Pittsburgh
Dr. Lawrence Crossett, Md, MD
Specialist — Payments: $5.3M
Dr. James Bradley, Md, MD
Specialist — Payments: $5.0M
Darrell Triulzi
Specialist — Payments: $3.3M
Dr. Mark Yazer, Md, MD
Specialist — Payments: $2.4M
Lirong Qu
Specialist — Payments: $2.4M
Dr. Miguel Regueiro, Md, MD
Specialist — Payments: $1.4M